A
Agilent Technologies, Inc.
Medical - Diagnostics & Research
Market Cap$33.31B
5Y Perf.+33.5%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
A vs BRKR
Revenue, margins, valuation, and 5-year total return — side by side.
BRKR
Bruker Corporation
Medical - Devices
Market Cap$6.44B
5Y Perf.-2.3%
A vs BRKR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | A | BRKR |
|---|---|---|
| Industry | Medical - Diagnostics & Research | Medical - Devices |
| Market Cap | $33.31B | $6.44B |
| Revenue (TTM) | $7.07B | $3.46B |
| Net Income (TTM) | $1.29B | $-26M |
| Gross Margin | 38.8% | 45.3% |
| Operating Margin | 20.6% | 4.9% |
| Forward P/E | 19.7x | 20.0x |
| Total Debt | $3.35B | $2.04B |
| Cash & Equiv. | $1.79B | $299M |
A vs BRKR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
A
BRKR
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Agilent Technologie… (A) | 100 | 133.5 | +33.5% |
| Bruker Corporation (BRKR) | 100 | 97.7 | -2.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: A vs BRKR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: A leads in 7 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
A
Agilent Technologies, Inc.
The Income Pick
A carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 10 yrs, beta 1.23, yield 0.8%
- Rev growth 6.7%, EPS growth 3.2%, 3Y rev CAGR 0.5%
- 202.6% 10Y total return vs BRKR's 59.6%
Best for: income & stability and growth exposure
BRKR
Bruker Corporation
The Specific-Use Pick
In this particular matchup, BRKR is outpaced on most metrics by others in the set.
Best for: healthcare exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | A | 6.7% revenue growth vs BRKR's 2.1% |
| Value | A | Lower P/E (19.7x vs 20.0x) |
| Quality / Margins | A | 18.3% margin vs BRKR's -0.8% |
| Stability / Safety | A | Beta 1.23 vs BRKR's 1.59, lower leverage |
| Dividends | A | 0.8% yield, 10-year raise streak, vs BRKR's 0.4% |
| Momentum (1Y) | A | +12.8% vs BRKR's +7.7% |
| Efficiency (ROA) | A | 10.1% ROA vs BRKR's -0.4%, ROIC 13.5% vs 4.4% |
A vs BRKR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
A vs BRKR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLALAGGINGBRKR
BRKRBruker Corporation
1leads
AAgilent Technologies,…
4leads
6 Total Categories
CATEGORYLEADERvs BRKRMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
A5/6
Valuation MetricsMultiples, price ratios, and targets
BRKR4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
A8/9
Total Returns1Y, 3Y, 5Y total returns with dividends
A5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
A2/2
Income & Cash Flow (Last 12 Months)
A leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
A is the larger business by revenue, generating $7.1B annually — 2.0x BRKR's $3.5B. A is the more profitable business, keeping 18.3% of every revenue dollar as net income compared to BRKR's -0.8%. On growth, A holds the edge at +7.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | AAgilent Technolog… | BRKRBruker Corporation |
|---|---|---|
| RevenueTrailing 12 months | $7.1B | $3.5B |
| EBITDAEarnings before interest/tax | $1.7B | $339M |
| Net IncomeAfter-tax profit | $1.3B | -$26M |
| Free Cash FlowCash after capex | $993M | $51M |
| Gross MarginGross profit ÷ Revenue | +38.8% | +45.3% |
| Operating MarginEBIT ÷ Revenue | +20.6% | +4.9% |
| Net MarginNet income ÷ Revenue | +18.3% | -0.8% |
| FCF MarginFCF ÷ Revenue | +14.1% | +1.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.0% | +2.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.6% | -81.8% |
A leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
BRKR leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, BRKR's 17.9x EV/EBITDA is more attractive than A's 19.7x.
| Metric | AAgilent Technolog… | BRKRBruker Corporation |
|---|---|---|
| Market CapShares × price | $33.3B | $6.4B |
| Enterprise ValueMkt cap + debt − cash | $34.9B | $8.2B |
| Trailing P/EPrice ÷ TTM EPS | 25.75x | -282.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.71x | 20.01x |
| PEG RatioP/E ÷ EPS growth rate | 1.75x | — |
| EV / EBITDAEnterprise value multiple | 19.74x | 17.93x |
| Price / SalesMarket cap ÷ Revenue | 4.79x | 1.87x |
| Price / BookPrice ÷ Book value/share | 4.96x | 2.56x |
| Price / FCFMarket cap ÷ FCF | 28.92x | 148.71x |
BRKR leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
A leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
A delivers a 18.7% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-1 for BRKR. A carries lower financial leverage with a 0.50x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRKR's 0.81x. On the Piotroski fundamental quality scale (0–9), A scores 5/9 vs BRKR's 4/9, reflecting solid financial health.
| Metric | AAgilent Technolog… | BRKRBruker Corporation |
|---|---|---|
| ROE (TTM)Return on equity | +18.7% | -1.1% |
| ROA (TTM)Return on assets | +10.1% | -0.4% |
| ROICReturn on invested capital | +13.5% | +4.4% |
| ROCEReturn on capital employed | +14.5% | +5.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.50x | 0.81x |
| Net DebtTotal debt minus cash | $1.6B | $1.7B |
| Cash & Equiv.Liquid assets | $1.8B | $299M |
| Total DebtShort + long-term debt | $3.4B | $2.0B |
| Interest CoverageEBIT ÷ Interest expense | 19.53x | 0.75x |
A leads this category, winning 8 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
A leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in A five years ago would be worth $9,234 today (with dividends reinvested), compared to $6,345 for BRKR. Over the past 12 months, A leads with a +12.8% total return vs BRKR's +7.7%. The 3-year compound annual growth rate (CAGR) favors A at -3.1% vs BRKR's -17.8% — a key indicator of consistent wealth creation.
| Metric | AAgilent Technolog… | BRKRBruker Corporation |
|---|---|---|
| YTD ReturnYear-to-date | -14.3% | -12.0% |
| 1-Year ReturnPast 12 months | +12.8% | +7.7% |
| 3-Year ReturnCumulative with dividends | -9.0% | -44.4% |
| 5-Year ReturnCumulative with dividends | -7.7% | -36.6% |
| 10-Year ReturnCumulative with dividends | +202.6% | +59.6% |
| CAGR (3Y)Annualised 3-year return | -3.1% | -17.8% |
A leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — A and BRKR each lead in 1 of 2 comparable metrics.
Risk & Volatility
A is the less volatile stock with a 1.23 beta — it tends to amplify market swings less than BRKR's 1.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | AAgilent Technolog… | BRKRBruker Corporation |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.23x | 1.59x |
| 52-Week HighHighest price in past year | $160.27 | $56.22 |
| 52-Week LowLowest price in past year | $104.36 | $28.53 |
| % of 52W HighCurrent price vs 52-week peak | +73.4% | +75.2% |
| RSI (14)Momentum oscillator 0–100 | 52.2 | 52.6 |
| Avg Volume (50D)Average daily shares traded | 2.0M | 1.9M |
Evenly matched — A and BRKR each lead in 1 of 2 comparable metrics.
Analyst Outlook
A leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates A as "Buy" and BRKR as "Buy". Consensus price targets imply 41.0% upside for A (target: $166) vs 23.2% for BRKR (target: $52). For income investors, A offers the higher dividend yield at 0.84% vs BRKR's 0.36%.
| Metric | AAgilent Technolog… | BRKRBruker Corporation |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $166.00 | $52.13 |
| # AnalystsCovering analysts | 38 | 32 |
| Dividend YieldAnnual dividend ÷ price | +0.8% | +0.4% |
| Dividend StreakConsecutive years of raises | 10 | 0 |
| Dividend / ShareAnnual DPS | $0.99 | $0.15 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.3% | +0.2% |
A leads this category, winning 2 of 2 comparable metrics.
Key Takeaway
A leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BRKR leads in 1 (Valuation Metrics). 1 tied.
Best OverallAgilent Technologies, Inc. (A)Leads 4 of 6 categories
Loading custom metrics...
A vs BRKR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is A or BRKR a better buy right now?
For growth investors, Agilent Technologies, Inc.
(A) is the stronger pick with 6. 7% revenue growth year-over-year, versus 2. 1% for Bruker Corporation (BRKR). Agilent Technologies, Inc. (A) offers the better valuation at 25. 8x trailing P/E (19. 7x forward), making it the more compelling value choice. Analysts rate Agilent Technologies, Inc. (A) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — A or BRKR?
On forward P/E, Agilent Technologies, Inc.
is actually cheaper at 19. 7x.
03Which is the better long-term investment — A or BRKR?
Over the past 5 years, Agilent Technologies, Inc.
(A) delivered a total return of -7. 7%, compared to -36. 6% for Bruker Corporation (BRKR). Over 10 years, the gap is even starker: A returned +202. 6% versus BRKR's +59. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — A or BRKR?
By beta (market sensitivity over 5 years), Agilent Technologies, Inc.
(A) is the lower-risk stock at 1. 23β versus Bruker Corporation's 1. 59β — meaning BRKR is approximately 29% more volatile than A relative to the S&P 500. On balance sheet safety, Agilent Technologies, Inc. (A) carries a lower debt/equity ratio of 50% versus 81% for Bruker Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — A or BRKR?
By revenue growth (latest reported year), Agilent Technologies, Inc.
(A) is pulling ahead at 6. 7% versus 2. 1% for Bruker Corporation (BRKR). On earnings-per-share growth, the picture is similar: Agilent Technologies, Inc. grew EPS 3. 2% year-over-year, compared to -119. 7% for Bruker Corporation. Over a 3-year CAGR, BRKR leads at 10. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — A or BRKR?
Agilent Technologies, Inc.
(A) is the more profitable company, earning 18. 8% net margin versus -0. 3% for Bruker Corporation — meaning it keeps 18. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: A leads at 21. 3% versus 6. 9% for BRKR. At the gross margin level — before operating expenses — A leads at 52. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is A or BRKR more undervalued right now?
On forward earnings alone, Agilent Technologies, Inc.
(A) trades at 19. 7x forward P/E versus 20. 0x for Bruker Corporation — 0. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for A: 41. 0% to $166. 00.
08Which pays a better dividend — A or BRKR?
All stocks in this comparison pay dividends.
Agilent Technologies, Inc. (A) offers the highest yield at 0. 8%, versus 0. 4% for Bruker Corporation (BRKR).
09Is A or BRKR better for a retirement portfolio?
For long-horizon retirement investors, Agilent Technologies, Inc.
(A) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 23), 0. 8% yield, +202. 6% 10Y return). Bruker Corporation (BRKR) carries a higher beta of 1. 59 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (A: +202. 6%, BRKR: +59. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between A and BRKR?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
A pays a dividend while BRKR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(A: 7.0% · BRKR: 2.7%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.